| scholarly article | Q13442814 |
| editorial | Q871232 |
| P50 | author | Ganesan Venkatasubramanian | Q35705209 |
| P2093 | author name string | Sri Mahavir Agarwal | |
| P2860 | cites work | Exercise therapy for schizophrenia | Q24235370 |
| Glycogen synthase kinase 3: more than a namesake | Q24315635 | ||
| A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia | Q28263942 | ||
| DISC1-binding proteins in neural development, signalling and schizophrenia | Q28302106 | ||
| Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis | Q33410679 | ||
| Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women | Q33942488 | ||
| New options for the treatment of obesity and type 2 diabetes mellitus (narrative review) | Q34070610 | ||
| Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample | Q34128452 | ||
| Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters | Q34321791 | ||
| Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia | Q34694021 | ||
| A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction | Q35008345 | ||
| Early life programming and neurodevelopmental disorders | Q35201642 | ||
| Schizophrenia and increased risks of cardiovascular disease | Q36336286 | ||
| Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway | Q37139258 | ||
| TCF7L2 genetic defect and type 2 diabetes | Q37150525 | ||
| Glucose abnormalities in the siblings of people with schizophrenia | Q37151239 | ||
| A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review | Q37352658 | ||
| Schizophrenia and physical health problems | Q37365412 | ||
| Schizophrenia, "just the facts" 4. Clinical features and conceptualization | Q37425853 | ||
| Metabolic syndrome associated with schizophrenia and atypical antipsychotics | Q37738743 | ||
| Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation | Q37908905 | ||
| Cognitive and behavioural effects of physical exercise in psychiatric patients | Q37961476 | ||
| Yoga in schizophrenia: a systematic review of randomised controlled trials | Q38001055 | ||
| The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia | Q38099103 | ||
| Glycogen synthase kinase 3-β: A master regulator of toll-like receptor-mediated chronic intestinal inflammation | Q38340778 | ||
| Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells | Q39923229 | ||
| C-reactive protein, vitamin B12 and C677T polymorphism of N-5,10-methylenetetrahydrofolate reductase gene are related to insulin resistance and risk factors for metabolic syndrome in Chinese population | Q42868357 | ||
| Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia | Q46453193 | ||
| Antipsychotics: is it time to introduce patient choice? | Q47307983 | ||
| Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study | Q47322944 | ||
| The 'boon and bane' of antipsychotic-induced metabolic syndrome | Q47671257 | ||
| Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormality | Q47959350 | ||
| At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. | Q51808997 | ||
| A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia. | Q51829491 | ||
| P433 | issue | 2 | |
| P921 | main subject | schizophrenia | Q41112 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 117-120 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Indian Journal of Psychological Medicine | Q6020819 |
| P1476 | title | Metabolic syndrome in schizophrenia: theoretical, clinical and translational perspectives | |
| P478 | volume | 35 |
| Q39427970 | Psychiatric disorders and obesity: A review of association studies | cites work | P2860 |
Search more.